ONWARD Medical Closes EUR 50.85 Million Private Placement

ONWARD Medical N.V., a leader in neurotechnology, has announced the closure of its private placement, raising gross proceeds of EUR 50,850,000. The new shares have been listed and are now trading on Euronext Brussels, Amsterdam, and Paris. This follows the company's continued efforts to advance therapies aimed at restoring movement for individuals with spinal cord injuries and other movement disabilities.

This financial move supports ONWARD's mission to develop innovative therapeutic solutions, further strengthening its position in the market. Notably, this private placement does not represent an offering of securities in any jurisdiction but is targeted at institutional investors.

As ONWARD progresses, investors are reminded of the inherent risks and variables in forward-looking statements, which could impact future outcomes.